chr3-41225443-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001904.4(CTNNB1):c.605T>C(p.Met202Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,613,816 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M202V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001904.4 missense
Scores
Clinical Significance
Conservation
Publications
- exudative vitreoretinopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- severe intellectual disability-progressive spastic diplegia syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
- exudative vitreoretinopathy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001904.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | NM_001904.4 | MANE Select | c.605T>C | p.Met202Thr | missense | Exon 5 of 15 | NP_001895.1 | ||
| CTNNB1 | NM_001098209.2 | c.605T>C | p.Met202Thr | missense | Exon 5 of 16 | NP_001091679.1 | |||
| CTNNB1 | NM_001098210.2 | c.605T>C | p.Met202Thr | missense | Exon 5 of 16 | NP_001091680.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | ENST00000349496.11 | TSL:1 MANE Select | c.605T>C | p.Met202Thr | missense | Exon 5 of 15 | ENSP00000344456.5 | ||
| CTNNB1 | ENST00000396183.7 | TSL:1 | c.605T>C | p.Met202Thr | missense | Exon 5 of 16 | ENSP00000379486.3 | ||
| CTNNB1 | ENST00000396185.8 | TSL:1 | c.605T>C | p.Met202Thr | missense | Exon 5 of 16 | ENSP00000379488.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250748 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461616Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727100 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74348 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 202 of the CTNNB1 protein (p.Met202Thr). This variant is present in population databases (rs587778222, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with CTNNB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 133953). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CTNNB1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at